CD309 Antibody [Avas12a1] (PE) | 76-993

CD309 Antibody [Avas12a1] (PE) | 76-993 | Gentaur UK, US & Europe Distribution

Host: Rat

Reactivity: Mouse

Homology: N/A

Immunogen: N/A

Research Area: Stem Cell

Tested Application: Flow

Application: N/A

Specificiy: The Avas12a1 monoclonal antibody specifically reacts with mouse CD309, also known as fetal liver kinase-1 (Flk-1) or the vascular endothelial growth factor receptor 2 (VEGFR2) .

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.

Clonality: Monoclonal

Clone: Avas12a1

Isotype: Rat IgG2a, kappa

Conjugate: PE

Physical State: liquid

Buffer: Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.

Concentration: batch dependent

Storage Condition: The product should be stored undiluted at 4˚C and should be protected from prolonged exposure to light. Do not freeze.

Alternate Name: Flk1, Ly73, Flk-1, Krd-1, VEGFR2, VEGFR-2, sVEGFR-2, 6130401C07, Kdr

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: The Avas12a1 monoclonal antibody specifically reacts with mouse CD309, also known as fetal liver kinase-1 (Flk-1) or the vascular endothelial growth factor receptor 2 (VEGFR2) . CD309 is a receptor for VEGF and VEGFC and is expressed in endothelial cells in embryonic and adult tissue and a requirement for the development of vascular endothelial and hematopoietic cells.